跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Quprin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Quprin
Approved
STANDARD
Quprin
BCWorld Pharma. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7ab2601a5759c7cf
Company
BCWorld Pharma. Co., Ltd.
Type
Standard
Approval Details
Approval Id
7ab2601a5759c7cf
Drug Approval Philippines Name
Quprin
Product Name
Quprin
Registration Number
DRP-8929
Brand Name
Quprin
Generic Name
Norepinephrine (as bitartrate)
Dosage Form
Solution for Injection (I.V.)
Dosage Strength
1 mg/mL (4 mg/4 mL and 10 mg/10 mL)
Manufacturer
BCWorld Pharma. Co., Ltd.
Importer
JLT Pharma, Inc.
Distributor
Uni-Pharma Phils., Inc.
Issuance Date
27 April 2025
Expiry Date
29 June 2031
Pharmacologic Category
Adrenergic/Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7ab2601a5759c7cf
Type
Standard
Back to Philippines FDA Approvals